Clinical trials
Rotator Cuff Tear Arthropathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 11 |
| Unknown status | 11 |
| Active, not recruiting | 4 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medacta International SA | 3 |
| Schulthess Klinik | 3 |
| Zimmer Biomet | 3 |
| Hospital del Mar | 2 |
| Limacorporate S.p.a | 2 |
| Stryker Trauma and Extremities | 2 |
| University of Missouri-Columbia | 2 |
| University of Utah | 2 |
| Arthrex, Inc. | 1 |
| Arthro Medics AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rotator Cuff Tear Arthropathy | 57 |
| Rotator Cuff Injuries | 11 |
| Osteonecrosis | 8 |
| Arthritis, Rheumatoid | 6 |
| Osteoarthritis | 5 |
| Fractures, Bone | 4 |
| Shoulder Fractures | 3 |
| Shoulder Pain | 3 |
| Arthritis, Psoriatic | 1 |
| Fractures, Malunited | 1 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.